medmix publishes a midyear report as well as an annual report.
In line with its vision of creating a cleaner beauty industry, GEKA has been awarded a B Supplier Engagement Rating (SER) by the CDP for reducing the climate impact of its supply chain. The rating builds on an overall climate change score of B for GEKA in 2021, illustrating how the high precision beauty application expert is taking a leading role in sustainable cosmetics.
Ad hoc announcement pursuant to Art. 53 LR
FULL YEAR 2021 HIGHLIGHTS
Established in 1922, MK™ develops innovative, high quality dispensers for sealant and adhesive materials, producing specialized and customized ranges of both single and dual-component dispensers.
As we celebrate the centennial anniversary of the MK brand (est. 1922) and its benefits of quality, reliability, and performance, medmix is now launching the first of a new generation of MK 1-component, manual dispensers with an improved look and feel, for long-lasting professional performance.
medmix, the global leader in high-precision delivery devices, is announcing its newly crafted sustainability policy. With a holistic approach that serves Planet, Profit and People, the policy will guide medmix towards its ambitious sustainability targets, ensuring that sustainability is reflected at all levels of the company.
Mixpac, a leading provider of high-precision delivery devices, has announced that it has joined the Adhesive and Sealant Council (ASC) as a new member. The ASC is a North American trade association dedicated to representing the adhesive and sealant industry, promoting knowledge sharing, and supporting future growth.
Ad hoc announcement pursuant to Art. 53 LR
medmix announced today that Itee Satpathy is to succeed Friedrich von Gadow as Chief Human Resources Officer and member of the Executive Committee, effective December 1, 2021. Friedrich von Gadow is returning to Sulzer as he has been appointed as Head Human Resources for Switzerland.
Ad hoc announcement pursuant to Art. 53 LR
Ad hoc announcement pursuant to Art. 53 LR.
medmix announces final offer price of CHF 45 per new medmix share, resulting in gross proceeds of CHF 315 million
medmix AG launches share offering and sets price range at CHF 37 to CHF 47 per share